4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-13-002656
Options or other derivatives
- Director acquired 287,500 shares (grant or award)
- Director returned 287,500 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| SAXE JON S Director | 2013-12-20 | Returned to the company · Stock Option (Right to Buy) | −7,500 | 0 | D | ||
| SAXE JON S Director | 2013-12-20 | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | D | ||
| SAXE JON S Director | 2013-12-20 | Returned to the company · Stock Option (Right to Buy) | −20,000 | 0 | D | ||
| SAXE JON S Director | 2013-12-20 | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | D | ||
| SAXE JON S Director | 2013-12-20 | Returned to the company · Stock Option (Right to Buy) | −150,000 | 0 | D | ||
| SAXE JON S Director | 2013-12-20 | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | D | ||
| SAXE JON S Director | 2013-12-20 | Returned to the company · Stock Option (Right to Buy) | −50,000 | 0 | D | ||
| SAXE JON S Director | 2013-12-20 | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | D | ||
| SAXE JON S Director | 2013-12-20 | Returned to the company · Stock Option (Right to Buy) | −10,000 | 0 | D | ||
| SAXE JON S Director | 2013-12-20 | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | D | ||
| SAXE JON S Director | 2013-12-20 | Returned to the company · Warrant for Common Stock | −50,000 | 0 | D | ||
| SAXE JON S Director | 2013-12-20 | Grant or award · Warrant for Common Stock | +50,000 | 50,000 | D | ||
Loading xslF345X03/form4-12262013_101208.xml…